Johnson & Johnson seeks USFDA nod for Tremfya for ulcerative colitis treatment in adults Ruchika Sharma12 March 2024 12:39 PM ISTSpring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
Latest JnJ talc trial ends with hung jury Ruchika Sharma8 March 2024 1:30 PM ISTNew York: The latest trial over claims that Johnson & Johnson's talc products cause cancer ended in a mistrial on Tuesday, as a Florida state...
USFDA nod to JnJ for Rybrevant, Chemotherapy combo for lung cancer treatment Anshika Mishra4 March 2024 5:09 PM ISTJohnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...
Health Bulletin 04/ March/ 2024 Anshika Mishra4 March 2024 4:44 PM ISTHere the top health news for the day :Lady hardinge medical college to introduce new DNB and FNB courses soon Bringing good news to the postgraduate...
Johnson and Johnson gets USFDA approval for Rybrevant, chemotherapy combo for lung cancer treatment Ruchika Sharma2 March 2024 2:33 PM ISTRaritan: Johnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...
Biocon Biologics secures US market entry date for Bmab 1200, a Proposed Biosimilar to Stelara Ruchika Sharma1 March 2024 3:30 PM ISTStelara (Ustekinumab) is a monoclonal antibody medication that prevents abnormal regulation of interleukin IL-12/23 associated immune diseases and has...
JnJ gets USFDA nod for Bi-weekly dose of blood cancer therapy Tecvayli Ruchika Sharma21 Feb 2024 11:39 AM ISTUnited States: The U.S. Food and Drug Administration has approved a bi-weekly dose of Johnson & Johnson's blood cancer therapy Tecvayli, the...
USFDA grants Breakthrough Therapy Designation for JnJ Nipocalimab for individuals at high risk for severe hemolytic disease of fetus, newborn Ruchika Sharma10 Feb 2024 12:06 PM ISTSpring House: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation...
JnJ to acquire Ambrx Biopharma for USD 2 billion Ruchika Sharma11 Jan 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Ambrx Biopharma, Inc., or Ambrx, a...
Judge certifies JnJ shareholder class action over talc disclosures Ruchika Sharma30 Dec 2023 1:30 PM ISTNew York: A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently...
Janssen seeks EMA marketing nod for Lazertinib plus Rybrevant for EGFR-Mutated Non Small Cell Lung Cancer Ruchika Sharma25 Dec 2023 3:30 PM ISTBelgium: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a marketing authorisation application...
JnJ seeks USFDA nod for Rybrevant plus Lazertinib for EGFR-Mutated Non-Small Cell Lung Cancer Ruchika Sharma24 Dec 2023 12:30 PM ISTRaritan: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
